A new weight loss injection called retatrutide has shown remarkable results in helping users shed weight quickly. However, recent research suggests that the drug, which is developed by the makers of ...

Insurer cites "significantly higher medical utilization with an expensive health care system, along with skyrocketing ...

Demi Moore, Nicole Kidman and Mindy Kaling are among the stars who stepped out with slimmed-down figures during awards season, a trend that one expert says could be due to a "combination of factors." ...

Blue Cross Blue Shield of Michigan reported a hefty $1.03 billion loss in 2024 as rising costs in the sector batter the health insurer's bottom line in “unsustainable” market conditions.

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...

Anti-obesity GLP-1 medications aren't as effective as bariatric surgery for weight loss and improving obesity-related conditions ...

As consumers who use GLP-1 drugs seek lean, protein-rich foods, the demand for ground turkey has been increasing.

Blue Cross Blue Shield of Massachusetts (BCBSMA), the state's largest health insurer, ended 2024 with a staggering $400.4 ...

Discover why Hims & Hers faces steep corrections amid GLP-1 headwinds and valuation concerns, despite promising FY2024 growth ...

AI is reshaping the food industry, engineering hyper-palatable foods that override hunger signals and manipulate cravings. Is ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Declining sugar consumption among people taking GLP-1 drugs to combat diabetes and obesity and the impact of President’s ...